Eli Lilly Receives FDA Approval for Crohn's Disease Treatment
Omvoh's approval as a treatment for Crohn's disease was based on results from a study in which 53% of patients treated with the drug achieved clinical remission, and 46% of patients had visible ...
These Stocks Are Moving the Most Today: JPMorgan, Wells Fargo, Goldman, Citigroup, BlackRock, Quantum Computing, and More
Stocks held onto a rally Wednesday as core U.S. consumer price inflation was cooler than expected in December and some of the ...
Lilly gets FDA approval for Omvoh for Crohn's disease
Eli Lilly (NYSE:LLY) has received FDA approval for its drug Omvoh, also known as mirikizumab-mrkz, for the treatment of ...
These Stocks Moved the Most Today: JPMorgan, Wells Fargo, Goldman, Citigroup, BlackRock, Quantum Computing, and More
Fourth-quarter earnings at JPMorgan Chase, Wells Fargo, Goldman Sachs, and Citigroup beat analysts’ estimates.